Skip to main content

Closed

AIM: AIM ImmunoTech Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-48.2% / yr

Operating margin-10839.4%

ROIC-152.1%

Financially safe

Stretched

Debt / equity2.15×

Interest coverage-10.3×

Current ratio1.01×

AIM ImmunoTech Inc.

AIMNew York Stock Exchange Arca·USD·Closed

AIM ImmunoTech Inc.

AIMNew York Stock Exchange Arca·USD·Closed

$0.26

−0.38%

$0.26

−$0.00 (0.38%)

52W Range

2thpctl

Volume

0.04×avg

Mkt Cap

895131USD

P/E

-0.1TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.04×avg

Market Cap

895131USD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings